Insider Buying: IDT Australia (ASX:IDT) Insider Buys 501,936 Shares of Stock

IDT Australia Limited (ASX:IDT) insider Mark Simari bought 501,936 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was purchased at an average cost of A$0.05 per share, with a total value of A$24,092.93.

IDT Australia Price Performance

The company has a current ratio of 1.34, a quick ratio of 4.15 and a debt-to-equity ratio of 19.06. The firm has a market capitalization of $48.61 million, a price-to-earnings ratio of -7.47 and a beta of 1.22.

IDT Australia Company Profile

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms.